Loading company…
Pittsburgh-based Thar Pharmaceuticals, Inc. works on therapeutic products and was acquired by Grünenthal Group in 2016.
Founded in 2008 in Pittsburgh, US, Thar Pharmaceuticals, Inc. engages in pharmaceutical development, particularly specialized therapeutic products. Grünenthal Group acquired the company in November 2016 for an undisclosed amount, and its most recent deal was dated November 16, 2016. The company has completed 10 deals and reports a total raised of USD 0.33 mn, with its latest round a Venture Debt of USD 1.37 mn. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in